New Dosage Formulations for Targeted Delivery of Cyclo-Oxygenase-2 Inhibitors
- 1 January 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs & Aging
- Vol. 24 (6), 441-451
- https://doi.org/10.2165/00002512-200724060-00001
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular RiskDrug Safety, 2006
- Albumin microspheres as carriers for the antiarthritic drug celecoxibAAPS PharmSciTech, 2005
- Cyclo-Oxygenase-2 InhibitorsDrugs & Aging, 2005
- Efficacy of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflamed jointsJournal of Pharmacy and Pharmacology, 2004
- Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppressionThe FASEB Journal, 2002
- Colorectal Polyps in the ElderlyDrugs & Aging, 2002
- Cyclo-Oxygenase-2 InhibitorsDrugs & Aging, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisThe New England Journal of Medicine, 2000
- NSAIDs and Blood PressureDrugs & Aging, 1998
- Ocular Mini-Tablets for Controlled Release of Timolol: Evaluation in RabbitsJournal of Ocular Pharmacology and Therapeutics, 1996